AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36137957 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS combined with cognitive training
Number of subjects: 60
Study 36137957 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training alone
Number of subjects: 60
Study 32205034 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable cardioverter-defibrillator (WCD)
Number of subjects: 0
Study 32205034 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34968130 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic planning
Number of subjects: 320
Study 34968130 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative planning
Number of subjects: 320
Study 34968130 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual planning
Number of subjects: 320
Study 34968130 — intervention group
Group type: COMPARATOR
Intervention: Control condition (physical activity, sedentary behavior, and nutrition education)
Number of subjects: 320
Study 33724890 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic analgesia (H)
Number of subjects: 205
Study 33724890 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic analgesia (H) + Virtual Reality distraction (VR)
Number of subjects: 205
Study 33724890 — intervention group
Group type: COMPARATOR
Intervention: Virtual Reality distraction (VR)
Number of subjects: 205
Study 33724890 — intervention group
Group type: COMPARATOR
Intervention: Hypnotic analgesia (H) alone
Number of subjects: 205
Study 32151528 — intervention group
Group type: EXPERIMENTAL
Intervention: Lens A (senofilcon A)
Number of subjects: 30
Study 32151528 — intervention group
Group type: EXPERIMENTAL
Intervention: Lens B (balafilcon A)
Number of subjects: 30
Study 36101515 — intervention group
Group type: EXPERIMENTAL
Intervention: Micellar curcumin (105 mg day-1) for 7 days
Number of subjects: 15
Study 36101515 — intervention group
Group type: COMPARATOR
Intervention: Native curcumin (105 mg day-1) for 7 days
Number of subjects: 15
Study 33225791 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental weight
Number of subjects: 411
Study 33225791 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental length
Number of subjects: 411
Study 33225791 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum cord diameter
Number of subjects: 411
Study 36209239 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide in addition to ongoing androgen deprivation therapy (ADT)
Number of subjects: 806
Study 36209239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 806
Study 33662954 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Sclerosis (MS)
Number of subjects: 4461
Study 32593255 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma enriched with platelets combined with traditional treatment
Number of subjects: 80
Study 32593255 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment alone
Number of subjects: 80
Study 35871950 — intervention group
Group type: EXPERIMENTAL
Intervention: OPF-105 (150 g dextrose, 60 g amino acids, 40 g fat, 1240 kcal per 2200 mL)
Number of subjects: 35
Study 35871950 — intervention group
Group type: COMPARATOR
Intervention: BFI (150 g dextrose, 60 g amino acids, 840 kcal per 2000 mL)
Number of subjects: 35
Study 35871950 — intervention group
Group type: EXPERIMENTAL
Intervention: OPF-105 (multiple doses for 3 days)
Number of subjects: 35
Study 35871950 — intervention group
Group type: COMPARATOR
Intervention: BFI (multiple doses for 3 days)
Number of subjects: 35
Study 34435993 — intervention group
Group type: EXPERIMENTAL
Intervention: Early exercise intervention (Group 1)
Number of subjects: 40
Study 34435993 — intervention group
Group type: COMPARATOR
Intervention: Later exercise intervention (Group 2)
Number of subjects: 40
Study 33123091 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg oral iodine daily until delivery
Number of subjects: 514
Study 33123091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 514
Study 35506470 — intervention group
Group type: EXPERIMENTAL
Intervention: WRAP®
Number of subjects: 182
Study 35506470 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 182
Study 34515669 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and Feedback report
Number of subjects: 833
Study 34515669 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 833
Study 35666855 — intervention group
Group type: EXPERIMENTAL
Intervention: Study formula (SF)
Number of subjects: 0
Study 35666855 — intervention group
Group type: COMPARATOR
Intervention: Commercial formula (CF)
Number of subjects: 0
Study 32680894 — intervention group
Group type: EXPERIMENTAL
Intervention: Domus intervention (specialised palliative home care with psychological intervention)
Number of subjects: 322
Study 32680894 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospice SPT (specialised palliative home teams)
Number of subjects: 322
Study 32680894 — intervention group
Group type: EXPERIMENTAL
Intervention: Domus intervention
Number of subjects: 322
Study 32680894 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 322
Study 32680894 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 322
Study 35149656 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led telephonic palliative care
Number of subjects: 4
Study 35149656 — intervention group
Group type: COMPARATOR
Intervention: Outpatient palliative care
Number of subjects: 4
Study 33683736 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided detection system (CADS) based on convolutional neural network (CNN)
Number of subjects: 65
Study 33683736 — intervention group
Group type: EXPERIMENTAL
Intervention: CADS
Number of subjects: 65
Study 32413774 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐Lok™ with G‐Lok‐XL™ (fixed loop)
Number of subjects: 27
Study 32413774 — intervention group
Group type: EXPERIMENTAL
Intervention: ProCinch™ with G‐Lok‐XL™ (adjustable loop)
Number of subjects: 27
Study 32413774 — intervention group
Group type: COMPARATOR
Intervention: G‐Lok™ (control with socket tunnel)
Number of subjects: 27
Study 35861301 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose calcineurin inhibitor (CNI) combined with sirolimus (SRL) after four weeks of standard regimen.
Number of subjects: 0
Study 35861301 — intervention group
Group type: COMPARATOR
Intervention: Standard care (CNI + MPA + glucocorticoid) maintained after four weeks.
Number of subjects: 0
Study 33964852 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily consumption of 3 whole Gala apples (∼200 g edible parts)/d for 6 weeks
Number of subjects: 46
Study 33964852 — intervention group
Group type: COMPARATOR
Intervention: Control group (avoided apples)
Number of subjects: 46
Study 32601731 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 32601731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35837181 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at bilateral Hegu (LI 4) and Neiguan (PC 6) points
Number of subjects: 54
Study 35837181 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 54
Study 33187518 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ) intake (140 mL, 12.8 mmol NO3‐)
Number of subjects: 12
Study 33187518 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ) intake
Number of subjects: 12
Study 33187518 — intervention group
Group type: COMPARATOR
Intervention: Placebo intake
Number of subjects: 12
Study 33367965 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 30
Study 33367965 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32622603 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-treated canola meal (CM) at 110°C for 10 min
Number of subjects: 28
Study 32622603 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol inclusion (0 or 5% on a dry matter basis)
Number of subjects: 28
Study 32622603 — intervention group
Group type: COMPARATOR
Intervention: Control group (CM without heat treatment)
Number of subjects: 28
Study 37034559 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 3.0 mg/day
Number of subjects: 27
Study 37034559 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study 32750730 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 40
Study 32750730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32430375 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a primary care physician (PCP)
Number of subjects: 400
Study 32430375 — intervention group
Group type: EXPERIMENTAL
Intervention: Native English speaking
Number of subjects: 400
Study 32430375 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Charlson comorbidity index score
Number of subjects: 400
Study 32430375 — intervention group
Group type: EXPERIMENTAL
Intervention: Identifying as women
Number of subjects: 400
Study 32430375 — intervention group
Group type: COMPARATOR
Intervention: Socioeconomic status score, quantity of contact information recorded at recruitment, and insurance status
Number of subjects: 400
Study 34688521 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage messages (sugary drink discouragement, water encouragement, or combined)
Number of subjects: 2164
Study 34688521 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage messages
Number of subjects: 2164
Study 34688521 — intervention group
Group type: COMPARATOR
Intervention: Control messages (school readiness)
Number of subjects: 2164
Study 32552433 — intervention group
Group type: COMPARATOR
Intervention: Pdimax50% (50% of maximal inspiratory mouth and transdiaphragmatic pressure)
Number of subjects: 8
Study 32552433 — intervention group
Group type: COMPARATOR
Intervention: Pdimax70% (70% of maximal inspiratory mouth and transdiaphragmatic pressure)
Number of subjects: 8
Study 32552433 — intervention group
Group type: COMPARATOR
Intervention: Control (no resistance)
Number of subjects: 8
Study 36418131 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically assisted hydration (CAH) including parenteral fluids (dextrose saline 4% dextrose, 0.18% sodium chloride)
Number of subjects: 1600
Study 36418131 — intervention group
Group type: COMPARATOR
Intervention: Usual end-of-life care (continuance of drinking, mouth care)
Number of subjects: 1600
Study 33820788 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise at an intensity of 4.5 METs for 150 min per week for 16 weeks
Number of subjects: 60
Study 33820788 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intensity group training at 6.0 METs for 150 min per week for 12 weeks
Number of subjects: 60
Study 33820788 — intervention group
Group type: COMPARATOR
Intervention: Maintained intensity group training at 4.5 METs for 150 min per week for 12 weeks
Number of subjects: 60
Study 32766705 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine group (TG) with access to a CCDSS platform
Number of subjects: 98
Study 32766705 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with treatment as usual (TAU)
Number of subjects: 98
Study 32766705 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 98
Study 33389660 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital storytelling (DS) intervention
Number of subjects: 40
Study 33389660 — intervention group
Group type: COMPARATOR
Intervention: Information control (IC)
Number of subjects: 40
Study 33740911 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 70
Study 33740911 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 70
Study 32362510 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (sexual violence education training for health center staff)
Number of subjects: 2291
Study 32362510 — intervention group
Group type: COMPARATOR
Intervention: Control (information about drinking responsibly)
Number of subjects: 2291
Study 35245661 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/day allopurinol
Number of subjects: 245
Study 35245661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 35028116 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes health education care model
Number of subjects: 90
Study 35028116 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 90
Study 34139038 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron 50 mg (V50)
Number of subjects: 0
Study 34139038 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron 100 mg (V100)
Number of subjects: 0
Study 34139038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34139038 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibegron (V50/100)
Number of subjects: 0
Study 32039871 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined scalp acupuncture and cognitive training
Number of subjects: 70
Study 32039871 — intervention group
Group type: COMPARATOR
Intervention: Sham scalp acupuncture and cognitive training
Number of subjects: 70
Study 33576579 — intervention group
Group type: EXPERIMENTAL
Intervention: New perioperative practice model with one named anaesthesia nurse
Number of subjects: 453
Study 33576579 — intervention group
Group type: COMPARATOR
Intervention: Standard perioperative care with various nurses
Number of subjects: 453
Study 32472663 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acustimulation (TEA)
Number of subjects: 108
Study 33567005 — intervention group
Group type: EXPERIMENTAL
Intervention: GII: color retinography + visual field
Number of subjects: 80
Study 33567005 — intervention group
Group type: EXPERIMENTAL
Intervention: GIII: color retinography + optical coherence tomography
Number of subjects: 80
Study 33567005 — intervention group
Group type: EXPERIMENTAL
Intervention: GIV: color retinography + visual field + optical coherence tomography
Number of subjects: 80
Study 33567005 — intervention group
Group type: COMPARATOR
Intervention: GI: color retinography
Number of subjects: 80
Study 33567005 — intervention group
Group type: COMPARATOR
Intervention: GI
Number of subjects: 80
Study 33567005 — intervention group
Group type: EXPERIMENTAL
Intervention: GII
Number of subjects: 80
Study 33567005 — intervention group
Group type: EXPERIMENTAL
Intervention: GIII
Number of subjects: 80
Study 33567005 — intervention group
Group type: EXPERIMENTAL
Intervention: GIV
Number of subjects: 80
Study 33274199 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 46
Study 33274199 — intervention group
Group type: COMPARATOR
Intervention: Tablet candy
Number of subjects: 46
Study 35051941 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS to facilitate contralesional dorsal premotor cortex (cPMd) in conjunction with task-oriented upper limb rehabilitation
Number of subjects: 24
Study 35051941 — intervention group
Group type: COMPARATOR
Intervention: rTMS to facilitate ipsilesional primary motor cortex (iM1) in conjunction with task-oriented upper limb rehabilitation
Number of subjects: 24
Study 34351721 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose anticoagulation with heparin
Number of subjects: 2219
Study 34351721 — intervention group
Group type: COMPARATOR
Intervention: Usual-care pharmacologic thromboprophylaxis
Number of subjects: 2219
Study 33964053 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered Tooth brushing (PT)
Number of subjects: 46
Study 33964053 — intervention group
Group type: COMPARATOR
Intervention: Manual Tooth brushing (MT)
Number of subjects: 46
Study 33964053 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PT and MT
Number of subjects: 46
Study 33826633 — intervention group
Group type: EXPERIMENTAL
Intervention: Pavlovian cue-conditioning paradigm with glucose and water delivery
Number of subjects: 5
Study 34121511 — intervention group
Group type: EXPERIMENTAL
Intervention: Boxing
Number of subjects: 40
Study 34121511 — intervention group
Group type: COMPARATOR
Intervention: Sensory Exercise
Number of subjects: 40
Study 32062614 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher left handgrip strength
Number of subjects: 0
Study 32062614 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher right handgrip strength
Number of subjects: 0
Study 32062614 — intervention group
Group type: COMPARATOR
Intervention: Genetically predicted CAD
Number of subjects: 0
Study 32062614 — intervention group
Group type: COMPARATOR
Intervention: Genetically instrumented body lean mass
Number of subjects: 0
Study 35689805 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS plus FDS
Number of subjects: 32
Study 35689805 — intervention group
Group type: COMPARATOR
Intervention: sham tDCS plus FDS
Number of subjects: 32
Study 33926267 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression probability model with urn or permuted block randomization method
Number of subjects: 0
Study 33926267 — intervention group
Group type: COMPARATOR
Intervention: Conventional beta-binomial probability model
Number of subjects: 0
Study 32966290 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel plus Dihydroartemisinin-piperaquine combination
Number of subjects: 639
Study 32966290 — intervention group
Group type: COMPARATOR
Intervention: Praziquantel alone
Number of subjects: 639
Study 32966290 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 639
Study 34615419 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil dairy drink
Number of subjects: 0
Study 34615419 — intervention group
Group type: COMPARATOR
Intervention: Non-lipid dairy drink
Number of subjects: 0
Study 34615419 — intervention group
Group type: COMPARATOR
Intervention: Pre-formed oleic acid micelle dairy drink
Number of subjects: 0
Study 34615419 — intervention group
Group type: COMPARATOR
Intervention: Fish oil dairy drink
Number of subjects: 0
Study 32657958 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish language TAPS Tool (self-administered)
Number of subjects: 100
Study 32657958 — intervention group
Group type: COMPARATOR
Intervention: Spanish language TAPS Tool (interviewer-administered)
Number of subjects: 100
Study 33332053 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP-363856
Number of subjects: 0
Study 33332053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35123454 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition program
Number of subjects: 8
Study 35123454 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support component
Number of subjects: 8
Study 35123454 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint transfer meeting
Number of subjects: 8
Study 35123454 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement of adolescents and healthcare professionals
Number of subjects: 8
Study 35123454 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual factors
Number of subjects: 8
Study 35123454 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard operating procedures
Number of subjects: 8
Study 33105946 — intervention group
Group type: EXPERIMENTAL
Intervention: PiCCO monitoring rehydration group
Number of subjects: 52
Study 33105946 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehydration group
Number of subjects: 52
Study 35612354 — intervention group
Group type: EXPERIMENTAL
Intervention: Developing Inclusive Youth program (classroom-based, individually administered video tool with teacher-led discussions)
Number of subjects: 983
Study 35612354 — intervention group
Group type: EXPERIMENTAL
Intervention: Developing Inclusive Youth program
Number of subjects: 983
Study 35612354 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 983
Study 33622326 — intervention group
Group type: EXPERIMENTAL
Intervention: VB‐HoLEP
Number of subjects: 200
Study 33622326 — intervention group
Group type: COMPARATOR
Intervention: HoLEP
Number of subjects: 200
Study 35139373 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal influenza vaccination
Number of subjects: 0
Study 35139373 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 34848479 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 51
Study 34848479 — intervention group
Group type: COMPARATOR
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 51
Study 35772819 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Joint Distraction (KJD)
Number of subjects: 344
Study 35772819 — intervention group
Group type: COMPARATOR
Intervention: Knee Replacement (KR)
Number of subjects: 344
Study 35772819 — intervention group
Group type: EXPERIMENTAL
Intervention: KJD
Number of subjects: 344
Study 35772819 — intervention group
Group type: COMPARATOR
Intervention: KR
Number of subjects: 344
Study 33546968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative fluid (IOF) administration at a rate of 11.90 mL/kg/h (higher IOF rate)
Number of subjects: 1040
Study 33546968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative fluid (IOF) administration at a higher rate
Number of subjects: 1040
Study 33546968 — intervention group
Group type: COMPARATOR
Intervention: Tri‐incisional esophagectomy
Number of subjects: 1040
Study 32847912 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) with a self-selected 10-hour eating window from 06:00 to 20:00
Number of subjects: 100
Study 32847912 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE)
Number of subjects: 100
Study 32847912 — intervention group
Group type: COMPARATOR
Intervention: Habitual living (control group)
Number of subjects: 100
Study 35908555 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sleeve gastroplasty (ESG) with lifestyle modifications
Number of subjects: 209
Study 35908555 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle modifications alone (control group)
Number of subjects: 209
Study 33511727 — intervention group
Group type: EXPERIMENTAL
Intervention: Opalescence Boost (OB) 40%
Number of subjects: 180
Study 33511727 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser‐assisted LaserWhite20 (LW20) 45%
Number of subjects: 180
Study 33511727 — intervention group
Group type: COMPARATOR
Intervention: Unbleached control group
Number of subjects: 180
Study 33511727 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond 2 (SB2) after 7 days
Number of subjects: 180
Study 35473649 — intervention group
Group type: EXPERIMENTAL
Intervention: Do More, Feel Better (DMFB)
Number of subjects: 56
Study 35473649 — intervention group
Group type: COMPARATOR
Intervention: Behavioral Activation delivered by social workers (MSW BA)
Number of subjects: 56